Marie‐Claude Fournié‐Zaluski

Author

Also Known As

B. P. ROQUES, Fournie-Zaluski, Marie-Claude, M C Fournie-Zaluski, MARIE‐CLAUDE FOURNIE‐ZALUSKI, Marie-Claude FOURNIE-ZALUSKI, Marie-Claude Fournie-Zaluski, Marie-Claude Fournié-Zaluski, Marie-Claude Fournié-Zaluski, Marie-Claudé Fournié-Zaluski, Marie‐Claude Fournie‐Zaluski

121

Publications

4.6K

Citations

H-Index

108

Concepts

All Affiliations

Inserm Centre National de la Recherche Scientifique Département de Pharmacochimie Moléculaire Université Paris Cité Pharmaleads (France)

About

Marie‐Claude Fournié‐Zaluski is an author at Inserm specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	31	53	2.8K
2	Natural Sciences	18	20	1.1K
3	Health Sciences	8	8	373
4	Social Sciences	5	5	361
5	Engineering	4	4	94

Marie‐Claude Fournié‐Zaluski

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes Marie‐Claude Fournié‐Zaluski, Pierre Chaillet, Romaine Bouboutou, European Journal of Pharmacology BiochemistryPotent InhibitorMedicineAnesthetic MechanismNeuropharmacology	1984	167
D‐Tyr—Ser—Gly—Phe—Leu—Thr, a highly preferential ligand for δ‐opiate receptors G. Gacel, Marie‐Claude Fournié‐Zaluski, Bernárd P. Roques FEBS Letters Molecular PharmacologyBiochemistryMedicineReceptor (Biochemistry)δ‐Opiate Receptors	1980	165
Antidepressant-type effects of endogenous enkephalins protected by systemic RB 101 are mediated by opioid δ and dopamine D1 receptor stimulation Ana Baamonde, Valérie Daugé, Mariano Ruiz‐Gayo, European Journal of Pharmacology Psychoactive DrugPsychiatryOpioid δMedicinePsychopharmacology	1992	125
Selective Protection of Methionine Enkephalin Released from Brain Slices by Enkephalinase Inhibition Gilles Patey, Sophie De La Baume, Jean‐Charles Schwartz, Science	1981	121
Conversion of Renal Angiotensin II to Angiotensin III Is Critical for AT <sub>2</sub> Receptor–Mediated Natriuresis In Rats Shetal H. Padia, Brandon A. Kemp, Nancy L. Howell, Hypertension HypertensionRenal Angiotensin IiRenal InflammationCardiovascular PharmacologyPharmacotherapy	2007	116
Characterization of Glu<sup>350</sup> as a Critical Residue Involved in the N-Terminal Amine Binding Site of Aminopeptidase N (EC 3.4.11.2): Insights into Its Mechanism of Action Nathalie Luciani, Cynthia Marie‐Claire, Emmanuel Ruffet, Biochemistry Protein ChemistryAminopeptidase NProtein FunctionCellular EnzymologyBiochemistry	1998	106
Differential Inhibition of Aminopeptidase A and Aminopeptidase N by New .beta.-Amino Thiols Eric N. Chauvel, Catherine Llorens‐Cortés, Pascale Coric, Journal of Medicinal Chemistry	1994	105
Aminopeptidase A contributes to the N‐terminal truncation of amyloid β‐peptide Jean Sévalle, Audrey Amoyel, Philippe Robert, Journal of Neurochemistry Protein FunctionAlzheimer's DiseaseAmyloid β‐PeptideBiochemistryProtein Folding	2009	102
Structure-Based Dissection of the Active Site Chemistry of Leukotriene A4 Hydrolase: Implications for M1 Aminopeptidases and Inhibitor Design Fredrik Tholander, A. Muroya, Bernard‐Pierre Roques, Chemistry & Biology Medicinal ChemistryBiochemistryLeukotriene A4 HydrolaseNatural SciencesEnzyme Catalysis	2008	97
The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesia Pierre Chaillet, Annie Coulaud, Jean‐Marie Zajac, European Journal of Pharmacology Pain DisordersPain MedicineMolecular PainPharmacotherapyMolecular Pharmacology	1984	95

Page 1